X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-07 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $85.00 | -132,527 | 165,361 | -44% | -$11,264,888 | |||||
2024-08-28 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $80.00 | -14,132 | 181,249 | -7% | -$1,130,560 | ||||||
2024-01-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $60.00 | -11,660 | 245,820 | -5% | -$699,600 | ||||||
| D | 2023-12-29 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $57.50 | -81,940 | 257,480 | -24% | -$4,711,550 | |||||
2023-09-20 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $55.00 | -15,867 | 270,356 | -6% | -$872,685 | ||||||
| D | 2023-05-16 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $53.60 | -63,339 | 286,247 | -18% | -$3,394,856 | |||||
| D | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $47.78 | -79,264 | 292,381 | -21% | -$3,787,234 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |